(Q28343066)

https://api.crossref.org/works/10.1136/BMJ.304.6825.495

2 December 2023

author name string

C. R. Bentley

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312376

12 September 2022

G. Davies

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312376

12 September 2022

W. A. Aclimandos

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312376

full work available at URL

12 September 2022

language of work or name

English

0 references

publication date

22 February 1992

0 references

https://europepmc.org/articles/PMC1881086

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312376

https://europepmc.org/articles/PMC1881086?pdf=render

12 September 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312376

https://www.bmj.com/content/304/6825/495.full.pdf

12 September 2022

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1312376

https://syndication.highwire.org/content/doi/10.1136/bmj.304.6825.495

2 December 2023

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1136/BMJ.304.6825.495

2 December 2023

0 references

304

0 references

issue

6825

0 references

page(s)

495-6

0 references

cites work

Tamoxifen retinopathy

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1881086

20 March 2017

Tamoxifen retinopathy.

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1881086

Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer

29 September 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1881086

Ocular toxicity of tamoxifen

29 September 2017

1 reference

12 December 2020

Tamoxifen retinopathy. A clinicopathologic report

1 reference

12 December 2020

Retinopathy caused by treatment with tamoxifen in low dosage

1 reference

12 December 2020

Tamoxifen retinopathy at low dosage

1 reference

12 December 2020

Controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer. Analysis at six years by Nolvadex Adjuvant Trial Organisation

9

1 reference

Crossref

DOI

https://api.crossref.org/works/10.1136/BMJ.304.6825.495

2 December 2023

Identifiers

DOI

0 references

PMC publication ID

1881086

0 references